ArticleOPEN ACCESS

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland

Neurodegenerative Diseases
DOI: 10.1159/000545799
4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Felbecker, A., Rouaud, O., Lathuiliere, A., Allali, G., Sollberger, M., Meyer-Heim, T., … Frisoni, G. B. (2025, October 1). Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland. Neurodegenerative Diseases. S. Karger AG. https://doi.org/10.1159/000545799

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free